Abstracts

Filters

Clear Filters

Monday, September 29

11:05 AM - 11:15 AM PT

206 - Durable Survival and Updated Safety of TQB2450 plus Anlotinib Maintenance Therapy in Limited-Stage Small Cell Lung Cancer: Extended Follow-Up from a Prospective Phase Ib Trial

Speaker: Meng, Xiangjiao - Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan
11:05 AM - 11:15 AM PT
11:15 AM - 11:25 AM PT
11:15 AM - 11:25 AM PT

214 - Impact of Palliative Radiation on Lymphopenia and Survival in Cancer Patients

Speaker: Kim, Joshua, BS - Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY
11:15 AM - 11:25 AM PT